Volume 1 · Issue 1 · June 2026
Open Access · Peer Reviewed · Quarterly
Bridging basic discovery, engineering and clinical practice in translational medicine.
TransMed is an open access, peer-reviewed journal. The aim of TransMed is to serve the multidisciplinary community of biomedical engineering. Each quarterly issue of TransMed presents basic, clinical, and engineering research articles, reviews, highlights, editorials, correspondences and short communications in the interdisciplinary field of nanotechnology, biology, medicine and engineering, as well as strategies for disease prevention, diagnosis, treatment, and assessment.
0
Issues per year
0%
Open access
2029
APC waived until 2029
3117-3977
ISSN
TransMed is an open access, peer-reviewed journal. The aim of TransMed is to serve the multidisciplinary community of biomedical engineering. Each quarterly issue of TransMed presents basic, clinical, and engineering research articles, reviews, highlights, editorials, correspondences and short communications in the interdisciplinary field of nanotechnology, biology, medicine and engineering, as well as strategies for disease prevention, diagnosis, treatment, and assessment.
Lefeng Wisdom (Shanghai) Technology Co., Ltd. — LEFENG TECH — is a publishing company dedicated to open-access, peer-reviewed journals in the medical and life sciences.
Latest research
Research article Chenghao Li, Yi Shen et al.
Cianidanol (Cian), also known as (+)-catechin, is a naturally occurring flavonoid found in medicinal plants including Camellia sinensis and Violae…
Read more
Review Lizhou Song, Yan Liao et al.
Immune checkpoints (ICs) are receptors that regulate immune responses through both activating and inhibitory mechanisms. Key pathways, including…
Read more
Review Xueting Li, Fang Yin et al.
The gut microbiota plays a fundamental role in maintaining host physiological homeostasis. Among the diverse metabolites produced by intestinal…
Read more
Research article Jiasu Li, Xue Fang et al.
Gut microbiota dysbiosis and metabolic disturbances are implicated in inflammatory bowel disease (IBD). Current probiotic therapies are limited by…
Read more
Research article Ying Qin, Yuntian Han et al.
Escherichia coli currently serves as a widely used tool for therapeutic protein production; however, the high accumulation of heterologous proteins…
Read more
Review Kamlesh Sahu, Trilochan Satapathy et al.
Nanocarriers have emerged as indispensable platforms for drug delivery, molecular imaging and precision diagnostics. Their rapidly expanding global…
Read moreFor authors
All article publishing charges for manuscripts submitted before 30 March 2029 are fully waived.
Article types, word limits, title page, abstract, keywords, highlights and graphical abstract requirements.
Read moreRequirements for hazardous materials, human and animal research, and clinical trial transparency.
Read moreHow the Editorial Board and in-house scientific editors handle your manuscript.
Read morePublished by
Lefeng Wisdom (Shanghai) Technology Co., Ltd. — LEFENG TECH — is a publishing company dedicated to open-access, peer-reviewed journals in the medical and life sciences.
Read moreAll article publishing charges for manuscripts submitted before 30 March 2029 are fully waived.
